Lilly CEO Presses China For Favorable Environment For Innovative Drugs
This article was originally published in PharmAsia News
Executive Summary
John Lechleiter wears several hats as Eli Lilly's CEO, one of them to convince China health authorities they need to provide an environment for innovation as they work to make necessary drugs accessible to the nation's huge population.